New understanding of chronic pain suggests new target for drug development
January 22, 2012 in Medical researchMillions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system. In their new study, the scientists found that DMS is produced at abnormally high levels in the spinal cords of rats with neuropathic pain and appears to cause pain when injected. The findings suggest inhibiting this molecule may be a fruitful target for drug development.
"We think that this is a big step forward in understanding and treating neuropathic pain, and also a solid demonstration of the power of metabolomics," said Gary J. Patti, a research associate at Scripps Research during the study, and now an assistant professor of genetics, chemistry, and medicine at Washington University in St. Louis. Patti is a lead author of the report on the study, which appeared online in the journal Nature Chemical Biology on January 22, 2012.
Scientists who want to understand what makes diseased cells different from healthy cells have often looked for differences in levels of gene expression or cellular proteinsapproaches known respectively as genomics and proteomics. Metabolomics, by contrast, concerns differences in the levels of small-molecule metabolites, such as sugars, vitamins, and amino acids, that serve as the building blocks of basic cellular processes. "These are the molecules that are actually being transformed during cellular activity, and tracking them provides more direct information on what's happening at a biochemical level," Patti said.
Metabolomics is increasingly used to find biochemical markers or signatures of diseases. One of the most relied-upon "metabolome" databases, METLIN, was set up at Scripps Research in 2005, and now contains data on thousands of metabolites found in humans and other organisms. However, in this case the research team hoped to do more than find a metabolic marker of neuropathic pain.
"The idea was to apply metabolomic analysis to understand the biochemical basis of the neuropathic pain condition and reveal potential therapeutic targets," said Gary Siuzdak, a senior investigator in the study, who is professor of chemistry and molecular biology and director of the Scripps Research Center for Metabolomics. "We call this approach 'therapeutic metabolomics'."
The scientists began with a standard model of neuropathic pain in lab rats. Patti, Siuzdak, and their colleagues sampled segments of a previously injured tibial leg nerve triggering neuropathic pain, as well as the rats' blood plasma and tissue from the rats' spinal cords. The scientists then determined the levels of metabolites in these tissues, and compared them to levels from control animals.
Unexpectedly, the scientists found that nearly all the major abnormalities in metabolite levels were present not in the injured leg nerve fiber, nor in blood plasma, but in tissue from the "dorsal horn" region of the spinal cord which normally receives signals from the tibial nerve and relays them to the brain. "After the nerve is damaged, it degrades and rebuilds itself at the site of the injury, but remodeling also occurs, possibly over a longer period, at the terminus of the nerve where it connects to dorsal horn neurons," Patti said.
Next, the researchers set up a test to see which of the abnormally altered metabolites in dorsal horn tissue could evoke signs of pain signaling in cultures of rat spinal cord tissue. One metabolite stood outa small molecule that didn't appear in any of the metabolome databases. Patti eventually determined that the molecule was DMS, an apparent byproduct of cellular reactions involving sphingomyelin, a major building block for the insulating sheaths of nerve fibers. "This is the first characterization and quantitation of DMS as a naturally occurring compound," Patti noted. When the scientists injected it into healthy rats, at a dose similar to that found in the nerve-injured rats, it induced pain.
DMS seems to cause pain at least in part by stimulating the release of pro-inflammatory molecules from neuron-supporting cells called astrocytes. Patti, Siuzdak, and their colleagues are now trying to find out more about DMS's pain-inducing mechanismsand are testing inhibitors of DMS production that may prove to be effective treatments or preventives of neuropathic pain.
"We're very excited about this therapeutic metabolomics approach," said Siuzdak. "In fact, we're already involved in several other projects in which metabolites are giving us a direct indication of disease biochemistry and potential treatments."
More information: "Metabolomics Implicates Dysregulated Sphingomyelin Metabolism in the Central Nervous System During Neuropathic Pain" Nature Chemical Biology.
-
Research offers hope in new treatment for spinal cord injuries
May 03, 2011 |
not rated yet |
0
-
Protein found that may provide relief from neuropathic pain
Dec 05, 2007 |
not rated yet |
0
-
Cone snails and plants used to develop oral drug for pain
Apr 15, 2008 |
not rated yet |
0
-
The protein that makes us remember pain
May 13, 2011 |
not rated yet |
0
-
Scientists provide groundbreaking new understanding of stem cells
May 02, 2010 |
not rated yet |
0
-
Remembrance of things future: Long-term memory sets the stage for visual perception
Dec 28, 2011 |
3.6 / 5 (13) |
4
-
Beyond brain scanning: Simultaneous high-resolution 3D neural imaging and photostimulation
Nov 28, 2011 |
5 / 5 (8) |
2
-
The error-correcting brain: New insights into the neurobiology of adaptive behavior
Oct 27, 2011 |
4.9 / 5 (10) |
6
-
The brain on drugs: Defining the neural anatomy and physiology of morphine on dopamine neurons
Oct 04, 2011 |
4.8 / 5 (4) |
1
-
Now see this: Anti-inflammatory treatment reverses stroke-induced compromise in sensory learning
Sep 22, 2011 |
4 / 5 (9) |
2
-
stomach not emptying
Feb 16, 2012
-
White reflections in photos in one eye
Feb 15, 2012
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
- More from Physics Forums - Medical Sciences
More news stories
Men's legs may be new source for hair transplants
(HealthDay) -- Doctors may have a leg up on baldness: Transplanting hair from a patient's legs to his head for what may be a more natural look.
Medical research
7 hours ago |
3.3 / 5 (3) |
2
Researchers solve puzzle of proteins linked to heart failure
Sudden cardiac death is a risk for patients with heart failure because the calcium inside their heart cells is not properly controlled and this can lead to an irregular heartbeat. New findings published in PLoS ONE, which ...
Medical research
11 hours ago |
5 / 5 (2) |
0
|
Researchers take a step forward in transplanting pig cells to regenerate human cartilage
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have studied for the first time the response of human NK cells (Natural Killer) against porcine chondrocytes (cartilage cells).
Medical research
12 hours ago |
5 / 5 (2) |
0
An 'off' switch for pain: Chemists build light-controlled neural inhibitor
Pain? Just turn it off! It may sound like science fiction, but researchers based in Munich, Berkeley and Bordeaux have now succeeded in inhibiting pain-sensitive neurons on demand, in the laboratory. The crucial element in ...
Medical research
13 hours ago |
5 / 5 (3) |
0
|
Applying medical imaging expertise to battles against kidney disease, nervous system disorder
(Medical Xpress) -- Promising efforts to improve detection of early-stage kidney disease and treat children with neurofibromatosis have earned grants for Arizona State University research projects from the ...
Medical research
15 hours ago |
5 / 5 (2) |
0
Mini molecules could help fight battle of aortic bulge
When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate ...
Research links circadian rhythms to sudden cardiac death
A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abn ...
Analysis of mTOR shows how the protein works, how new generation of drugs may defeat it
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered ...
Phobia's effect on perception of feared object allows fear to persist
The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.
New melanoma drug Zelboraf nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Study: No significant rise in seizure risk from common kids' vaccine
(HealthDay) -- Children who receive a combination vaccine known as DTaP-IPV-Hib have no significant increased risk of febrile seizure, a convulsion triggered by a fever, during the week after vaccination, ...